ARTICLE | Clinical News
Synthetic retrotransposon vectors regulatory update
March 6, 2000 8:00 AM UTC
Nature Technology received U.S. Patent No. 6,027,722 covering the transfer of genes through the use of synthetic retrotransposon vectors that contain gene sequences derived from mobile genetic element...